Changes in spirometry and pulmonary diffusing capacity in Mexican Hispanics approximately one year after having severe COVID-19: A dataset.

Publication date: Dec 01, 2024

This observational longitudinal study was conducted at the Long-term follow-up COVID-19 Clinic in McE9rida, Mexico, from March to August 2021. A total of 100 patients hospitalized for severe COVID-19 were enrolled. Inclusion criteria required participants to be adults over 18, recovering from severe COVID-19 as defined by the World Health Organization (oxygen saturation below 90 %, severe pneumonia, or signs of severe respiratory distress). Exclusion criteria included pneumonia from non-SARS-CoV-2 causes, mild or moderate COVID-19, or a single follow-up evaluation. Pulmonary function tests were conducted at approximately 100 and 400 days after diagnosis. The dataset includes 82 patients with baseline and follow-up spirometry, pulmonary diffusing capacity and alveolar volume. Morbidity history and fibrosis scores from high-resolution CT scans were also obtained. Finally, fitted z-scores for spirometry and pulmonary diffusing capacity were acquired from established reference equations. The freely accessible data (Version 4) is provided in both SPSS (. sav) and .csv format. at the Mendeley Data cloud-based repository and includes nominal data, ordinal data, and scalar data.

Open Access PDF

Concepts Keywords
Adults Airway obstruction
August COVID-19
Clinic Lung diffusing capacity
Mexican Restriction
Pneumonia SARS CoV-2
Spirometry

Semantics

Type Source Name
disease MESH pulmonary diffusing capacity
disease MESH COVID-19
drug DRUGBANK Oxygen
disease MESH pneumonia
disease MESH causes
disease MESH Morbidity
disease IDO history
disease MESH fibrosis
drug DRUGBANK Coenzyme M
disease MESH Respiratory Diseases
disease MESH Airway obstruction
disease MESH pulmonary fibrosis
disease MESH sequelae
disease MESH abnormalities
disease MESH chest pain
disease MESH sore throat
disease MESH smell loss
disease MESH joint pain
disease MESH tachycardia
disease MESH sweating
disease MESH hair loss
disease MESH weight loss
disease MESH inflammation
drug DRUGBANK Carbon monoxide
disease IDO symptom
drug DRUGBANK Bentiromide
drug DRUGBANK Vildagliptin
disease MESH systemic sclerosis

Original Article

(Visited 1 times, 1 visits today)